Department of Health and Social Care
Approval for new trial to prevent Group B Strep in newborn babies
Ethical approval has been given for a £2.8 million trial to prevent Group B Strep being passed on to newborn babies.
Health Minister Nadine Dorries has announced that the Group B Strep trial has been given ethical approval by the Health Research Authority in England and Health and Care Research in Wales.
Group B Strep is the most common cause of life-threatening infection in newborn babies, causing a range of serious infections including pneumonia, meningitis and sepsis.
The results of the trial will be used to inform the future of pregnancy care across the United Kingdom and could help save babies’ lives.
The trial will involve 80 hospitals in England, Wales and Scotland and at least 320,000 women will take part. Recruitment will start in spring 2020.
The trial will be funded by the National Institute for Health Research (NIHR). It will look at the effectiveness of 2 different tests compared with standard care:
- a lab-based test, the Enriched Culture Medium (ECM) test at 35 to 37 weeks of pregnancy
- a ‘bedside test’ at the start of labour
The ECM test is currently recommended for use on high-risk groups in late pregnancy by the Royal College of Obstetricians and Gynaecologists’ clinical guidelines.
Group B Strep infections in newborn babies can usually be prevented by giving antibiotics through a vein to women during labour, which reduces the risk by up to 90%.
The UK currently does not routinely test pregnant women for Group B Strep, and instead identifies pregnant women with risk factors for their newborn developing the infection.
Research has shown:
- a 31% rise in the prevalence of Group B Strep infections in babies under 3 months old since 2000 in the UK and Ireland with 65% of the mothers of affected babies showing no risk factors
- the bacteria are present in approximately 1 in 5 pregnant women, usually causing no harm to the carrier, but may be passed unknowingly from a mother to her baby around birth
- one in 1,750 newborn babies will develop a Group B Strep infection. One in 19 of these babies will die and 1 in 14 survivors will be left with long-term disability
Health Minister Nadine Dorries said:
Every baby deserves the best start to life, so I’m thrilled this hugely important trial has been given the green light.
This is an issue I’ve been closely involved with for some time and I’m determined to do everything I can to raise awareness and help protect mothers and their newborns from the devastating impact this infection can have.
We want the NHS to be the safest place in the world to give birth and this trial will be an important step in understanding if universal screening of Group B Strep can save the lives of more babies.
Jane Plumb MBE, Chief Executive of Group B Strep Support, said:
We are delighted that the GBS3 trial is progressing and has the support of the government. This major trial is comparing 2 types of testing versus a risk-factor approach. The results will drive improvements in UK and international policy and lead to fewer babies and their families suffering the trauma that Group B Strep infection can bring.
After routine testing was introduced in the United States, the rate of early-onset Group B Strep infection dropped by over 80% and is now less than half that of the UK. Were the same to happen in the UK, approximately 350 babies every year would be protected from Group B Strep infections, saving 15 babies’ lives and preventing another 15 from developing life-changing disability.
Latest News from
Department of Health and Social Care
More than 1 in 10 people in England have now been tested for coronavirus25/09/2020 16:10:00
NHS Test and Trace has now reached almost half a million people, including those testing positive and their contacts, to slow the transmission of coronavirus in England.
UK Government local coronavirus testing site opens in Aberdeen25/09/2020 14:43:00
A new UK Government funded walk-through coronavirus testing facility opened yesterday in the University of Aberdeen’s Roy Strathdee building.
14,199 more NHS nurses and nursing student acceptances rise by 23%25/09/2020 10:10:10
The number of nurses in the NHS in England has increased by 14,199 compared with last year, and the number of doctors has risen by 9,283 .
NHS COVID-19 app launches across England and Wales24/09/2020 10:11:00
NHS COVID-19 app launches to help control coronavirus (COVID-19) transmission.
Update from the UK Chief Medical Officers on the COVID-19 alert level22/09/2020 15:10:00
A joint statement from the UK CMOs recommending that the UK COVID-19 alert level move from level 3 to level 4.
Childcare to be exempt from interhousehold mixing restrictions in local areas of intervention22/09/2020 14:08:00
Informal childcare and caring arrangements will be allowed to continue across the nation, the Health Secretary yesterday announced.
Chief Scientific Advisor and Chief Medical Officer briefing on coronavirus (COVID-19): 21 September 202022/09/2020 13:22:00
Sir Patrick Vallance and Professor Chris Whitty yesterday gave a data briefing on coronavirus.
New measures in response to the acceleration of coronavirus22/09/2020 12:18:00
Health and Social Care Secretary Matt Hancock yesterday spoke about the government response to the recent acceleration of coronavirus, including an isolation support payment and testing allocation.
New parents urged to have their say on available early years support via new online questionnaire21/09/2020 16:10:00
The review will consider the barriers that impact on early years development, including social and emotional factors, and early childhood experiences.